Sight Sciences Releases Second Quarter Results and Raises Full-Year Guidance

Published on August 8, 2025
MENLO PARK, Calif.—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, yesterday announced its financial results for the second quarter ended June 30, 2025 and raised its revenue guidance while reaffirming its adjusted operating expense guidance, both for full year 2025. Revenue for the second quarter of 2025 was $19.6 million, a decrease of 8 percent compared with the prior-year period, the company noted. Sight Sciences said it is raising its revenue guidance expectations for full year 2025 to $72.0 million to $76.0 million, versus prior revenue guidance of $70.0 million to $75.0 million.
Continue reading on website
Other news

Parental lag time is primary reason for delayed diagnosis and treatment of retinoblastoma

August 7, 2025
Ocular salvage and preservation of vision are essentially dependent on early diagnosis, and several studies have been conducted to identify the factors leading to delayed diagnosis at presentation.

The future of optometry: Dr Rachelle Lin taking the low vision world by storm

August 8, 2025
Rachelle Lin, OD, MS, FAAO, has refined her passions for academia, teaching, low vision practice, and advocacy work to build out a well-rounded career.